This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

A Prospective Study Comparing Urgent Video Capsule Endoscopy With Urgent Double-balloon Enteroscopy

This study has been completed.
Information provided by (Responsible Party):
Satimai Aniwan, M.D., King Chulalongkorn Memorial Hospital Identifier:
First received: July 30, 2012
Last updated: July 31, 2012
Last verified: July 2012
Overt obscure gastrointestinal bleeding (OGIB) is a distinct clinical entity with significantly worse outcomes compared with colonic bleeding and upper GI bleeding. The mortality rate for patients with acute small bowel bleeding was 10%.1 Recently, a meta-analysis of 10 studies showed that VCE and DBE have an equivalent diagnosis yields in patients with obscure GIB (62% for VCE and 56% for DBE).2 The limitation of this meta-analysis study was that the included studies examined patients with occult OGIB and overt OGIB. Comparing with occult OGIB, patients with overt OGIB are more likely to present a significant lesion that causes a recurrent bleeding which subsequently increases risk of morbidity and mortality.3 According to emergency endoscopy concept from upper and lower GIB, patients with overt OGIB have been demonstrated the usefulness of urgent VCE and urgent DBE in a diagnosis tool with an impact on clinical management.4-7 Although previous studies showed promising data about the use of urgent enteroscopy, the debate about using VCE or DBE first in patients with massive overt OGIB is still uncertain. Thus in this study, we conducted the prospective study to compare urgent VCE with urgent DBE in patients with massive overt OGIB.

Condition Intervention Phase
Overt Obscure Gastrointestinal Bleeding Device: video capsule endoscopy Device: double balloon enteroscopy Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Prospective Study Comparing Urgent Video Capsule Endoscopy With Urgent Double-balloon Enteroscopy in Patients With Massive Overt Obscure Gastrointestinal Bleeding

Resource links provided by NLM:

Further study details as provided by Satimai Aniwan, M.D., King Chulalongkorn Memorial Hospital:

Primary Outcome Measures:
  • detection rate of bleeding cause [ Time Frame: 1 day ]

Secondary Outcome Measures:
  • rebleeding rate [ Time Frame: one year ]

Enrollment: 27
Study Start Date: October 2010
Study Completion Date: March 2012
Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: video capsule endoscopy
Video capsule endoscopy is performed every recruited patient.
Device: video capsule endoscopy
Active Comparator: double balloon enteroscopy
Double balloon enteroscopy is performed after video capsule endoscopy in every recruited patient. (Tandem study)
Device: double balloon enteroscopy

  Show Detailed Description


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • The consecutive patients with massive overt OGIB defined as a visible gastrointestinal bleeding (GIB) (eg, melena or hemotochezia) of unknown origin that persists after an initial negative esophagogastroduodenoscopy (EGD) and colonoscopy were recruited. Massive was defined as the need for at least 3 units of blood transfusion. All patients underwent an EGD and colonoscopy within the first 48 hrs of hospitalization.

Exclusion Criteria:

  • Exclusion Criteria pregnancy, patients with a suspected intestinal obstruction or stricture, cardiac pacemaker implantation or other electromedical device implantation, diabetic gastroparesis, a history of gastrectomy and small bowel surgery.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01654770

Gastroenterology Unit, King Chulalongkorn Memorial Hospital
Patumwan, Bangkok, Thailand, 10330
Sponsors and Collaborators
King Chulalongkorn Memorial Hospital
Principal Investigator: Vichai Viriyatsahakul, MD, MSc Gastroenterology unit, King Chulalongkorn Memorial Hospital
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Satimai Aniwan, M.D., Principal investigator, King Chulalongkorn Memorial Hospital Identifier: NCT01654770     History of Changes
Other Study ID Numbers: SA-001
Study First Received: July 30, 2012
Last Updated: July 31, 2012

Keywords provided by Satimai Aniwan, M.D., King Chulalongkorn Memorial Hospital:

Additional relevant MeSH terms:
Gastrointestinal Hemorrhage
Pathologic Processes
Gastrointestinal Diseases
Digestive System Diseases processed this record on September 19, 2017